Cough Responses to Tussive Agents in Health and Disease (NCT01297790) | Clinical Trial Compass
CompletedNot Applicable
Cough Responses to Tussive Agents in Health and Disease
United Kingdom102 participantsStarted 2009-11
Plain-language summary
The sensitivity of a persons cough reflex can be measured by getting them to breath in (inhale) irritant chemicals. The purpose of this clinical research study is to test the sensitivity of the cough reflex to a variety of chemicals that can be inhaled to see if coughing responses are different between healthy people and people with respiratory problems that make them cough.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* General
* Adult subjects aged 18 years and over
* Meet criteria for subject groups as outlined below
(1) Healthy volunteers
* Non-smokers
* No history of respiratory disease
(2) Healthy smokers
* Current smokers with smoking history of ≥10 pack years
* Spirometry within normal limits i.e. FEV1\>80% predicted and FEV1/FVC ratio \>75% predicted
(3) Asthma
* Physician diagnosis of asthma
* Airways hyperresponsiveness to methacholine; PC20\<16mg/ml (within last 2 years)
* Non-smokers or ex-smoker with smoking history of ≤10 pack years
(4) COPD
* Physician diagnosis of COPD
* Ex-smokers with smoking history of ≥20 pack years
* Spirometry demonstrating airflow obstruction i.e. FEV1/FVC ratio \<70%
(5) Chronic Cough
* History of a dry cough for \>8 weeks
* Normal CXR
* Non-smokers or ex-smoker with smoking history of ≤10 pack years
Exclusion Criteria:
* 1\) Symptoms of upper respiratory tract infection within the last 6 weeks 2) Participation in another clinical trial of an investigational drug within the last 4 weeks 3) Use of medication likely to alter cough reflex sensitivity i.e. ACE inhibitors, codeine phosphate, morphine sulphate, 4) Patients with severe respiratory disease i.e. FEV1 \< 1 litre, 5) Significant medical co-morbidities likely to affect ability to participate in the trial or affect cough reflex sensitivity e.g. diabetes, stroke, Parkinson's disease, multiple sclerosis etc.